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BACKGROUND
Cardiac arrhythmias are a frequent complication related to seizures [1] . Most are benign although some, such as high-grade atrioventricular block, asystole, atrial fibrillation (AF), and ventricular fibrillation are potentially harmful. Indeed, several studies suggest that cardiac dysfunction may be the primary underlying cause of sudden death in epileptic patients (SUDEP). Post-ictal atrial fibrillation (PIAF) is a very rare cardiac arrhythmia associated with seizures, and its relevance is currently unknown. AF characteristics include: 1) irregular R-R intervals, 2) absence of distinct repeating P waves, and 3) irregular atrial activity [2] . Atrial flutter is differentiated from AF because of the characteristic "saw tooth" waves on the ECG instead of the chaotic 
perampanel after multiple antiepileptic drug trials. Interestingly, within the family history it was found that both maternal grandparents required the implantation of a pacemaker and that a maternal uncle also had an implantable cardioverter-defibrillator (ICD).
During admission, perampanel and lacosamide were withdrawn. The EEG showed a slow background rhythm (6-7 Hz). Interictal activity consisted of bifrontal symmetrical spike-and-waves and frontotemporal polyspikes. The patient presented a GTCS that commenced with a bifrontal symmetrical spike-wave followed by bilateral symmetrical ictal activity. After the seizure he was deeply unreactive for 20 minutes, in correlation with a post-ictal generalized electroencephalographic suppression (PGES) pattern ( Figure 1 ).
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[2-column image; does not need to be printed in colour]. The ECG-channel of the video-EEG (XLTEK EMU128FS) showed no abnormality during the 24h previous to the seizure. Muscle artefact precluded its visualization during the tonic-clonic phase, but when this ended a sinus tachycardia was observed. [4]. In these four cases, as well as ours, the duration of the arrhythmia was very short and therefore almost impossible to detect on an outpatient basis. It is thus probable that PIAF occurs more frequently than reported and is underdiagnosed.
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Although the physiopathological mechanisms of PIAF are not well defined, direct or indirect autonomic changes are likely to be involved. All but one reported case of PIAF occurred after a GTCS [1] . Following a GTCS there is a period of severe autonomic dysregulation dominated by a sympathetic over activation coupled with parasympathetic suppression in the early postictal phase; whereas the later phase seems to be dominated by impaired vagal recovery. The magnitude and duration of these autonomic alterations strongly correlate with PGES, which is associated with greater respiratory dysfunction, arousal impairment, and autonomic dysregulation. It is noteworthy that in our case, since PGES began simultaneously with the PIAF ( Figure   1 ). The autonomic imbalance and the abrupt loss of central modulation after a GTCS can jointly generate an arrhythmogenic stimulus which would ultimately lead to a paroxysmal AF [5] .
In our case, some of the recognized SUDEP risk biomarkers are present. The first is the prolonged PGES pattern, which correlated with a prolonged postictal period. The current criteria for PGES include the immediate postictal (within 30 seconds), generalized absence of electroencephalographic activity >10µV in amplitude, allowing for muscle, movement, breathing, and electrode artefacts [6] . In the MORTEMUS study, PGES was observed in all the SUDEP patients [7] suggesting that suppression of brain activity related to this pattern could lead to an inhibition of cardiorespiratory
As it was demonstrated, generalized tonic-clonic seizures increase the risk of SUDEP [7] . However, this survey evaluated cases studied in EMUs which mostly tend to evaluate patients with focal epilepsy for presurgical diagnosis. Refractory genetic generalized epilepsies that occur with tonic-clonic seizures should also be considered at high-risk for SUDEP. In fact, genetic epilepsies associated with specific neurocardiac channelopathies such as SCN1A or KCNA1 between others, involve an established increased SUDEP risk [8] . In our case, the 22q13 deletion syndrome (Phelan-McDermid syndrome) has not been associated with cardiac arrhythmias or sudden death. Although, it is interesting to note that the SHANK3, a gene with limited tissue distribution, it is expressed both on cardiomyocytes and neurons. In fact, twentyfive percent of patients diagnosed with this syndrome develop epilepsy, although no defined electroclinical syndrome or interictal findings are associated [9] .
AF can trigger cardiac failure and severe hemodynamic repercussion although in most cases it is asymptomatic and a low-mortality arrhythmia. In a retrospective study of SUDEP patients, 56% had ictal-triggered cardiac rhythm or repolarization disturbances, but they showed no differences with the control population. Nonetheless, it was remarkable that two of nine patients presented AF, which is not a frequent seizureinduced arrhythmia [4] .
The therapeutic objectives for paroxysmal AF non-related to epilepsy are the maintenance of sinus rhythm and prevention of peripheral embolization [2] . It is worthwhile considering whether or not PIAF needs to be treated, since seizure control would prevent this arrhythmia. Due to their proarrhythmic effect, the use of sodiumchannel blockers should be avoided. Lacosamide can produce dose-related increase in mean PR interval, and less frequently atrioventricular block. There are a few published cases of AF due to lacosamide, although these cases occurred with high doses and concomitant treatment with other sodium-channel blockers [10] [11]. In our patient, both episodes of AF were registered after discontinuing lacosamide, so it should not be
9 considered as part of the pathogenic mechanism. When seizure-control is not possible, the indication of antiarrhythmic drugs is controversial, as the pathophysiology of PIAF
has not yet been elucidated. Implantation of a pacemaker should only be evaluated when symptomatic bradycardia is associated; permanent pacing is not indicated for the prevention of AF in patients without other indications for pacemaker implantation [2] .
PIAF has to be considered at the same thromboembolic risk as for every paroxysmal AF unrelated to epilepsy, and therefore the indication of oral anticoagulants should be the same in both cases, according to the personal risk of embolization and haemorrhage [2] .
On the other hand, the risk of SUDEP is unclear, nevertheless, as AF is considered a low-mortality arrhythmia, an implantable cardioverter-defibrillator is not generally indicated, although each case should be individually assessed. At least one basal ECG have to be performed in every patient with refractory epilepsy and especially previous to a VEEG monitoring. Also, it is mandatory to include an ECG-channel in all VEEG recordings for the evaluation of peri-ictal cardiac arrhythmias. It is imperative to perform a thorough cardiac evaluation when PIAF is diagnosed, since some of these arrhythmias may be related to structural or arrhythmogenic cardiomyopathy, which are independent risk factors for sudden death. It is strongly recommended close surveillance until normal recovery has been achieved is strongly recommended after every seizure. Current available seizure alert and detection devices may be useful in these cases, although their value remains to be demonstrated in studies designed ad hoc.
CONCLUSION
Post-ictal atrial fibrillation is a very infrequent seizure complication. Nevertheless, its real prevalence is probably underdiagnosed since this is a usually short-lasting
